Table 3: HRME performance.

Reference

Year

Pathology

Sensitivity

Specificity

Accuracy

Vila, et al. [33]

2014

Esophageal adenocarcinoma

90%

82%

90%

Lee, et al. [67]

2014

Esophageal adenocarcinoma

100%

94.90%

95%

Protano, et al. [34]

2015

Esophageal squamous cell carcinoma

90%

89%

90%

Shin, et al. [68]

2015

Esophageal squamous cell carcinoma

84-93%

92-97%

94%

Parikh, et al. [71]

2015

Colon cancer

94%

95%

94%

Varela, et al. [72]

2013

Anal cancer

90%

88%